The U.S. Food and Drug Administration authorized and approved updated COVID boosters on Monday amid rising cases and hospitalizations across the country.

Next, an independent advisory panel from the Centers for Disease Control and Prevention will meet on Sept. 12 to provide recommendations on who should be eligible for the new booster. The final step will be sign-off from the CDC director.

This is a developing story. Please check back for updates.